April 17th 2025
How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.
Q&A With Miruna Sasu, president and CEO, COTA, Inc.
April 20th 2022From exposing disparities in care to guiding better patient outcomes to helping reign in the costs of care, the use of real-world data (RWD) in oncology can have far-reaching effects. Here’s how one RWD company exec is using her experience to help drive that change.
Q&A With Ignacio Medina, founder, Zetta Genomics
March 24th 2022Genomic data is transforming precision medicine—but progress depends on it being easily available where it’s needed. Pharmaceutical Executive speaks to Ignacio Medina, founder of Cambridge University spinout Zetta Genomics, to see how next-generation open-source data technologies accelerate discovery in the lab and patient benefit in the clinic.